270
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Trimethoprim/Sulfamethoxazole and Azithromycin Combination Therapy for Ocular Toxoplasmosis

, MD, , MD, , MD, , MD & , MD
Pages 289-291 | Received 16 Oct 2008, Accepted 09 Dec 2008, Published online: 15 Sep 2009

REFERENCES

  • Dodds E M. Ocular toxoplasmosis: Clinical presentation, diagnosis and therapy. Focal Points: Clinical Modules for Ophthalmologists. American Academy of Ophthalmology, San Francisco 1999; Vol. 17: 10
  • Holland G N, O'Connor G R, Belfort R, Remington J S. Toxoplasmosis. Ocular Infection & Immunity, J S People, G N Holland, K R Wilhelmus. Mosby-Year Book, St. Louis, MO 1996; 1083–1223
  • Dodds E M. Toxoplasmosis. Curr Opin Ophthalmol 2006; 17: 557–561
  • Rothova A, Bosch-Driessen L E, van Loon N H, Treffers W F. Azithromycin for ocular toxoplasmosis. Br J Ophthalmol 1998; 82: 1306–1308
  • Rothova A, Meenken C, Buitenhuis H J, et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 1993; 115: 517–523
  • Opremcak E M, Scales D K, Sharpe M R. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis. Ophthalmology 1992; 99: 920–925
  • Huskinson-Mark J, Araujo F G, Remington J S. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis 1991; 164: 170–171
  • Silveira C, Belfort R, Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002; 134: 41–46
  • McCannel C A, Holland G N, Helm C J, Cornell P J, Winston J V, Rimmer T G. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996; 121: 35–46
  • Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm 2004; 12: 297–310
  • Holland G N, Lewis K G. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002; 134: 102–114
  • Acers T E. Toxoplasmic retinochoroiditis: a double blind therapeutic study. Arch Ophthalmol 1964; 71: 58–62
  • Stanford M R, See S E, Jones L V, Gilbert R E. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 2003; 110: 926–931
  • Bosch-Driessen L E, Berendschot T T, Ongkosuwito J V, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002; 109: 869–878
  • Bosch-Driessen L H, Verbraak F D, Suttorp-Schulten M SA, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002; 134: 34–40
  • Katlama C, De Wit S, O'Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996; 22: 268–275

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.